INTERNATIONAL PATENT: TIZONA THERAPEUTICS, INC. FILES APPLICATION FOR "COMBINATION THERAPY INVOLVING ANTI-HLA-G ANTIBODIES AND ANTI- EGFR ANTIBODIES OR ANTI-PD-1 ANTIBODIES"

GENEVA, Dec. 2 -- TIZONA THERAPEUTICS, INC. (611 Gateway Blvd.Suite 221South San Francisco, California 94080-2005) filed a patent application (PCT/US2025/030417) for "COMBINATION THERAPY INVOLVING ANTI-HLA-G ANTIBODIES AND ANTI- EGFR ANTIBODIES OR ANTI-PD-1 ANTIBODIES" on May 21, 2025. With publication no. WO/2025/245256, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BEERS, Courtney (c/o Tizona Therapeutics, Inc.611 Gateway Blvd. Suite 221South San Francisco, California 94080-2005), O'BRIEN, Christine (c/o Tizona Therap...